Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates-Reference-Cited by-同舟云学术

Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates

Published:1997-12-15 Issue:S12 Volume:80 Page:2591-2610
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Behr Thomas M.,Sharkey Robert M.,Sgouros George,Blumenthal Rosalyn D.,Dunn Robert M.,Kolbert Katherine,Griffiths Gary L.,Siegel Jeffry A.,Becker Wolfgang S.,Goldenberg David M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. editor. Cancer imaging with radiolabeled antibodies. Boston: Kluwer Academic Publishers, 1990.

2. editor. Cancer therapy with radiolabeled antibodies. Boca Raton: CRC Press, 1995.

3. Successful Radioimmuno-therapy for Lung Metastasis of Human Colonic Cancer in Nude Mice

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model;Molecular Cancer Therapeutics;2023-07-24

2. Reduction of the Renal Radioactivity of ¹¹¹In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes;Journal of Medicinal Chemistry;2023-06-16

3. ²²⁵Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors;Journal of Nuclear Medicine;2022-11-17

4. Upregulation of Somatostatin Receptor Type 2 in a Receptor-Deficient In Vivo Pancreatic Neuroendocrine Tumor Model Improves Tumor Response to Targeted ¹⁷⁷Lu-DOTATATE;2022-04-26

5. Nephrotoxicity after radionuclide therapies;Translational Oncology;2022-01